Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15526 - 15550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	SYNGR2	9144	downregulated	Bortezomib results in decreased expression of SYNGR2 mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	TAGLN2	8407	downregulated	Bortezomib results in decreased expression of TAGLN2 mRNA	1q23.2	A21434
Bortezomib	Approved Investigational	TANK	10010	upregulated	Bortezomib results in increased expression of TANK mRNA	2q24.2	A21434
Bortezomib	Approved Investigational	TBC1D9	23158	upregulated	Bortezomib results in increased expression of TBC1D9 mRNA	4q31.21	A21434
Bortezomib	Approved Investigational	TBCD	6904	downregulated	Bortezomib results in decreased expression of TBCD mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	TBL1X	6907	upregulated	Bortezomib results in increased expression of TBL1X mRNA	Xp22.31-p22.2	A21434
Bortezomib	Approved Investigational	TCEAL1	9338	upregulated	Bortezomib results in increased expression of TCEAL1 mRNA	Xq22.2	A21438
Bortezomib	Approved Investigational	TCF19	6941	downregulated	Bortezomib results in decreased expression of TCF19 mRNA	6p21.33	A21437
Bortezomib	Approved Investigational	TCF4	6925	upregulated	Bortezomib results in increased expression of TCF4 mRNA	18q21.2	A21438
Bortezomib	Approved Investigational	TCF7	6932	downregulated	Bortezomib results in decreased expression of TCF7 mRNA	5q31.1	A21434
Bortezomib	Approved Investigational	TCF7L2	6934	upregulated	Bortezomib results in increased expression of TCF7L2 mRNA	10q25.2-q25.3	A21438
Bortezomib	Approved Investigational	TDGF1	6997	upregulated	Bortezomib results in increased expression of TDGF1 mRNA	3p21.31	A21438
Bortezomib	Approved Investigational	TFDP1	7027	downregulated	Bortezomib results in decreased expression of TFDP1 mRNA	13q34	A21434
Bortezomib	Approved Investigational	THEM6	51337	downregulated	Bortezomib results in decreased expression of THEM6 mRNA	8q24.3	A21434
Bortezomib	Approved Investigational	THRA	7067	downregulated	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of THRA mRNA	17q21.1	A21436
Bortezomib	Approved Investigational	THY1	7070	downregulated	Bortezomib results in decreased expression of THY1 mRNA	11q23.3	A21434
Bortezomib	Approved Investigational	TICAM2	353376	upregulated	Bortezomib results in increased expression of TICAM2 mRNA	5q22.3	A20714
Bortezomib	Approved Investigational	TLR2	7097	upregulated	Bortezomib results in increased expression of TLR2 mRNA	4q31.3	A20714
Bortezomib	Approved Investigational	TLR4	7099	upregulated	Bortezomib results in increased expression of TLR4 mRNA	9q33.1	A21438
Bortezomib	Approved Investigational	TM2D2	83877	upregulated	Bortezomib results in increased expression of TM2D2 mRNA	8p11.22	A21434
Bortezomib	Approved Investigational	TM2D3	80213	upregulated	Bortezomib results in increased expression of TM2D3 mRNA	15q26.3	A21434
Bortezomib	Approved Investigational	TMEM230	29058	downregulated	Bortezomib results in decreased expression of TMEM230 mRNA	20p13-p12.3	A21434
Bortezomib	Approved Investigational	TMEM254	80195	downregulated	Bortezomib results in decreased expression of TMEM254 mRNA	10q22.3	A21434
Bortezomib	Approved Investigational	TMEM263	90488	upregulated	Bortezomib results in increased expression of TMEM263 mRNA	12q23.3	A21434
Bortezomib	Approved Investigational	TMEM41B	440026	upregulated	Bortezomib results in increased expression of TMEM41B mRNA	11p15.4	A21434

Displaying entries 15526 - 15550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability